Clinical Trial: A Single‑Arm Exploratory Study of the Efficacy and Safety of Entinostat in Combination with Adebrelimab as Second‑Line Therapy for Extensive‑Stage Small Cell Lung Cancer (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single‑Arm Exploratory Study of the Efficacy and Safety of Entinostat in Combination with Adebrelimab as Second‑Line Therapy for Extensive‑Stage Small Cell Lung Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130652

Registration Time: 2026/08/23

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336163

Published by HT Digital Content Services with permission from Health Daily Digest....